ABI
ACHN

Adamant Biomedical Investments’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Adamant Biomedical Investments’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q4 		$1.23M Buy
100,000
+20,000
+25% +$245K 0.29% 78
2014
Q3 		$798K Buy
+80,000
New +$798K 0.2% 81